{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:47:41Z","timestamp":1786592861557,"version":"build-2736575974"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:italic>Staphylococcus aureus<\/jats:italic> bloodstream infections are associated with a high morbidity and mortality. Nevertheless, significance of a positive blood culture with this pathogen is often underestimated or findings are misinterpreted as contamination, which can result in inadequate diagnostic and therapeutic consequences. We here review and discuss current diagnostic and therapeutic key elements and open questions for the management of <jats:italic>Staphylococcus aureus<\/jats:italic> bloodstream infections.<\/jats:p>","DOI":"10.3389\/fmed.2020.616524","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T04:21:51Z","timestamp":1614918111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Management of Staphylococcus aureus Bloodstream Infections"],"prefix":"10.3389","volume":"7","author":[{"given":"Aurelia","family":"Kimmig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bahrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1469-0691.2012.03903.x","article-title":"The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jinf.2018.08.015","article-title":"Survival following Staphylococcus aureus bloodstream infection: a prospective multinational cohort study assessing the impact of place of care","volume":"77","author":"Nambiar","year":"2018","journal-title":"J Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","article-title":"Staphylococcus aureus: new evidence for intracellular persistence","volume":"17","author":"Garzoni","year":"2009","journal-title":"Trends Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmi.2016.06.020","article-title":"Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain","volume":"22","author":"Strobel","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/emmm.201000115","article-title":"Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection","volume":"3","author":"Tuchscherr","year":"2011","journal-title":"EMBO Mol Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/CMR.00069-15","article-title":"Clinical significance and pathogenesis of staphylococcal small colony variants in persistent infections","volume":"29","author":"Kahl","year":"2016","journal-title":"Clin Microbiol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.amjmed.2015.09.006","article-title":"Clinical presentation, risk factors, and outcomes of hematogenous prosthetic joint infection in patients with Staphylococcus aureus bacteremia","volume":"129","author":"Tande","year":"2016","journal-title":"Am J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1055\/s-2008-1046715","article-title":"Epidemiology, course and prognosis of Staphylococcus aureus bacteremia-preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort","volume":"133","author":"Seifert","year":"2008","journal-title":"Dtsch Med Wochenschr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia - a systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J Infect."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1055\/a-0816-9947","article-title":"Infektiologische Konsile bei Patienten mit Staphylococcus-aureus-Bakteri\u00e4mie \u2013 eine retrospektive Beobachtungsstudie am Universit\u00e4tsklinikum Jena","volume":"143","author":"Kimmig","year":"2018","journal-title":"Dtsch Med Wochenschr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia","volume":"57","author":"L\u00f3pez-Cort\u00e9s","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1055\/a-0756-8263","article-title":"Staphylococcus-aureus-Blutstrominfektion \u2013 eine interdisziplin\u00e4re Herausforderung","volume":"54","author":"Hagel","year":"2019","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/clind\/24.4.584","article-title":"The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults","volume":"24","author":"Weinstein","year":"1997","journal-title":"Clin Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0002-9343(78)90824-0","article-title":"The association between Staphylococcus aureus bacteremia and bacteriuria","volume":"65","author":"Lee","year":"1978","journal-title":"Am J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00063-018-0406-1","article-title":"Urosepsis","volume":"113","author":"Pletz","year":"2018","journal-title":"Med Klin Intensivmed Notfmed."},{"key":"B17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2334-10-225","article-title":"Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study","volume":"10","author":"Chihara","year":"2010","journal-title":"BMC Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MD.0b013e31824d7ed2","article-title":"Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia","volume":"91","author":"Vos","year":"2012","journal-title":"Medicine."},{"key":"B20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3238\/arztebl.2018.0445","article-title":"The diagnosis and treatment of pacemaker-associated infection","volume":"115","author":"D\u00f6ring","year":"2018","journal-title":"Dtsch \u00c4rztebl Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1086\/427806","article-title":"Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia","volume":"40","author":"Fowler","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0195-6701(98)90022-6","article-title":"Positive intravenous line tip cultures as predictors of bacteraemia","volume":"40","author":"Peacock","year":"1998","journal-title":"J Hosp Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1086\/524077","article-title":"Bacteremic complications of intravascular catheters colonized with Staphylococcus aureus","volume":"46","author":"Ekkelenkamp","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-020-04286-x","article-title":"Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"100","author":"B\u00f6ll","year":"2021","journal-title":"Ann Hematol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine."},{"key":"B27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ejechocard\/jer023","article-title":"Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography","volume":"12","author":"Rasmussen","year":"2011","journal-title":"J Echocardiogr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.echo.2017.03.007","article-title":"Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: a meta-analysis","volume":"30","author":"Bai","year":"2017","journal-title":"J Am Soc Echocardiogr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the european society of cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/cid\/civ235","article-title":"Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia","volume":"61","author":"Palraj","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jinf.2003.10.010","article-title":"Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia","volume":"48","author":"Lesens","year":"2004","journal-title":"J Infect."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy381","article-title":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology","volume":"67","author":"Miller","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B34","first-page":"59","volume-title":"Blutkulturdiagnostik: Sepsis, Endokarditis, Katheterinfektionen, Teil II","author":"Seifert","year":"2007"},{"key":"B35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-662-54507-2_167","article-title":"Patient blood management","volume-title":"Die An\u00e4sthesiologie","author":"Meybohm","year":"2019"},{"key":"B36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmi.2019.03.010","article-title":"Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia","volume":"25","author":"Weis","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMra1807761","article-title":"Penicillin allergy","volume":"381","author":"Castells","year":"2019","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"E291","DOI":"10.1111\/1469-0691.12169","article-title":"Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence","volume":"19","author":"Forstner","year":"2013","journal-title":"Clin Microbiol Infect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"van Hal","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance","volume":"200","author":"Bae","year":"2009","journal-title":"J Infect Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes","volume":"70","author":"Minejima","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"Prasad","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2146\/ajhp160006","article-title":"Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"74","author":"White","year":"2017","journal-title":"Am J Health Syst Pharm."},{"key":"B57","doi-asserted-by":"publisher","first-page":"ofz028","DOI":"10.1093\/ofid\/ofz028","article-title":"Dalbavancin as secondary therapy for serious Staphylococcus aureus infections in a vulnerable patient population","volume":"6","author":"Bryson-Cahn","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S772","DOI":"10.1093\/ofid\/ofz360.1933","article-title":"The use of dalbavancin for Staphylococcus aureus bacteremia in persons who inject drugs (PWID)","volume":"6","author":"van Hise","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine."},{"key":"B61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13063-015-0973-x","article-title":"Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial","volume":"16","author":"Kaasch","year":"2015","journal-title":"Trials."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/cid\/civ120","article-title":"Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study","volume":"60","author":"Bai","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cir320","article-title":"Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia","volume":"53","author":"Kaasch","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/MD.0b013e318294a710","article-title":"Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia","volume":"92","author":"Khatib","year":"2013","journal-title":"Medicine."},{"key":"B65","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jinf.2016.02.003","article-title":"The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia","volume":"72","author":"Tubiana","year":"2016","journal-title":"J Infect."},{"key":"B66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14503\/THIJ-15-5359","article-title":"Clinical risk factors for infective endocarditis in Staphylococcus aureus bacteremia","volume":"44","author":"Salvador","year":"2017","journal-title":"Tex Heart Inst J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1093\/jac\/dkz342","article-title":"Development of quality indicators for the management of Staphylococcus aureus bacteraemia","volume":"74","author":"Oever","year":"2019","journal-title":"J Antimicrob Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1128\/AAC.01021-12","article-title":"Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study","volume":"57","author":"Chong","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1473-3099(20)30590-9","article-title":"Staphylococcus aureus bacteraemia: does duration matter?","volume":"20","author":"Tong","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"558","DOI":"10.7326\/0003-4819-84-5-558","article-title":"Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection","volume":"84","author":"Iannini","year":"1976","journal-title":"Ann Intern Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/clinids\/14.1.75","article-title":"Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review","volume":"14","author":"Raad","year":"1992","journal-title":"Clin Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/PL00011278","article-title":"Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia","volume":"20","author":"Zeylemaker","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archinte.1995.00430110069007","article-title":"Staphylococcus aureus catheter-associated bacteremia","volume":"155","author":"Malanoski","year":"1995","journal-title":"Arch Intern Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-0042-120983","article-title":"Kontroversen im Management schwerer Staphylokokkeninfektionen","volume":"142","author":"Rieg","year":"2017","journal-title":"DMW Dtsch Med Wochenschr."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1093\/jac\/dkaa144","article-title":"Combination therapy with rifampicin or fosfomycin in patients with Staphylococcus aureus bloodstream infection at high risk for complications or relapse: results of a large prospective observational cohort","volume":"75","author":"Rieg","year":"2020","journal-title":"J Antimicrob Chemother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cmi.2016.08.026","article-title":"Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients","volume":"23","author":"Rieg","year":"2017","journal-title":"Clin Microbiol Infect."},{"key":"B77","doi-asserted-by":"publisher","first-page":"365","DOI":"10.21203\/rs.2.23809\/v1","article-title":"Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial","volume":"15","author":"Karlsen","year":"2020","journal-title":"J Orthop Surg Res."},{"key":"B78","article-title":"Adjunctive daptomycin in the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a randomized controlled trial","volume-title":"Clin Infect Dis.","author":"Cheng","year":"2020"},{"key":"B79","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e033391","DOI":"10.1136\/bmjopen-2019-033391","article-title":"Hospital-wide ELectronic medical record evaluated computerised decision support system to improve outcomes of patients with staphylococcal bloodstream infection (HELP): study protocol for a multicentre stepped-wedge cluster randomised trial","volume":"10","author":"Hagel","year":"2020","journal-title":"BMJ Open."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e013976","DOI":"10.1136\/bmjopen-2016-013976","article-title":"Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial","volume":"7","author":"Weis","year":"2017","journal-title":"BMJ Open."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.616524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T04:21:58Z","timestamp":1614918118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.616524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":81,"alternative-id":["10.3389\/fmed.2020.616524"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.616524","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"article-number":"616524"}}